São Paulo — September 20, 2021 — RapidAI, a global leader in cerebral image analysis (neuroimaging) that has revolutionized the stroke treatment workflow and decision-making process, would like to congratulate hospitals Albert Einstein, Hospital das Clínicas de Ribeirão Preto, Hospital Moinhos de Vento and Hospital São José Joinville for their recent certification by the World Stroke Organization (WSO) and the Iberoamerican Society of Cerebrovascular Diseases (SIECV).
These institutions were officially certified by the WSO and the Iberoamerican SIECV this Monday following a Board Review after meeting international patient care quality standards.
As exclusive neuroimaging partner in the WSO/SIEVC project, RapidAI combines its AI stroke image analysis platform with an exclusive training program for each type of certification to help Latin-American hospitals meet the strict standards for each WSO certification level, which in turn helps improve patient care.
“The Certification Program guarantees full access to the tools needed to provide these services, reducing the level of mortality and lesions this devastating disease can cause. Stroke Center representatives can access the platform and self-assess their hospitals. If they are eligible for certification, they then have to submit their documents for prior analysis and then receive an in-person inspection. The results are later assessed by international experts, who award certification,” explained Dr. Sheila Martins, president-elect of the Stroke Centers.
Dr. Greg Albers, Professor of Neurology at Stanford University, Director of the Stanford Stroke Center and cofounder of RapidAI, expects the program to continue providing healthcare specialists with the scientific evidence they need on which to base their decisions and adopt clear performance metrics that will create an environment in which quality can continuously improve.
“Hospitals are always looking to improve their diagnostic abilities and increase stroke unit efficiency. The Rapid platform can do this more accurately and effectively. We have already seen an improvement in stroke patient outcomes and this has already improved patient quality of life”, he noted.
RapidAI is already available in over 1,800 hospitals across 60 countries. It is the most widely used cerebrovascular imaging platform in the world for stroke patient care, research and clinical trials and plans to support certification of more than 100 advanced stroke centers across Latin America next year.
“One in four people will have a stroke in their lifetime. Having innovative technology such as the RapidAI makes a real difference when caring for Latin American patients. We are proud to be able to support an increasing number of hospitals that are investing in certification and adopting best practices. We want to support them throughout this benchmark patient care process,” said Renato Cunha, VP of Sales and Operations, LATAM at RapidAI.